[1] Sohni A, Verfaillie CM. Mesenchymal stem cells migration homing and tracking. Stem Cells Int. 2013;2013:130763.
[2] Kim EJ, Kim N, Cho SG. The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. Exp Mol Med. 2013;45:e2.
[3] Sharma RR, Pollock K, Hubel A, et al. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. 2014;54(5):1418-1437.
[4] Beane OS, Darling EM. Isolation, characterization, and differentiation of stem cells for cartilage regeneration. Ann Biomed Eng. 2012;40(10):2079-2097.
[5] Matsumoto T, Kuroda R, Mifune Y, et al. Circulating endothelial/skeletal progenitor cells for bone regeneration and healing. Bone. 2008;43(3):434-439.
[6] 彭俊琼,袁伟杰.肾脏尿酸转运体对调节尿酸的影响及尿酸在氧化应激中的双重作用[J].中华肾脏病杂志,2011,27(11):862-864.
[7] Ames BN, Cathcart R, Schwiers E, et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858-6862.
[8] Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004; 20:781-810.
[9] Macsai CE, Foster BK, Xian CJ. Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair. J Cell Physiol. 2008;215(3):578-587.
[10] Liu G, Vijayakumar S, Grumolato L, et al. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol. 2009;185(1):67-75.
[11] Augello A, De Bari C. The regulation of differentiation in mesenchymal stem cells. Hum Gene Ther. 2010;21(10): 1226-1238.
[12] Chen Y, Alman BA. Wnt pathway, an essential role in bone regeneration. J Cell Biochem. 2009;106(3):353-362.
[13] Bultink IE, Vis M, van der Horst-Bruinsma IE, et al. Inflammatory rheumatic disorders and bone. Curr Rheumatol Rep. 2012;14(3):224-230.
[14] Krause U, Gregory CA. Potential of modulating Wnt signaling pathway toward the development of bone anabolic agent. Curr Mol Pharmacol. 2012;5(2):164-173.
[15] MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009; 17(1):9-26.
[16] Cadigan KM, Liu YI. Wnt signaling: complexity at the surface. J Cell Sci. 2006;119(Pt 3):395-402.
[17] 许兵,刘慧,许应星,等.成骨细胞中经典Wnt/β-catenin通路研究进展[J].生命科学, 2011, 23(5):477-481.
[18] 张山山,杨乃龙,徐丽丽,等.尿酸对人骨髓间充质干细胞成骨分化中Cbfα1/Runx2表达的影响[J].中国骨质疏松杂志,2013,19(4): 363-366.
[19] 杨乃龙,朱晓琳,张冬.不同浓度尿酸对人骨髓间充质干细胞增殖的影响[J].中华临床医师杂志,2012,6(17):5145-5148.
[20] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南(2011年)[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(1): 2-17.
[21] 罗树君,曾荣,胡资兵.骨质疏松症的药物治疗进展[J].中国当代医药,2012,19(18):14-15.
[22] Nuttall ME, Gimble JM. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol. 2004;4(3): 290-294.
[23] Clabaut A, Delplace S, Chauveau C, et al. Human osteoblasts derived from mesenchymal stem cells express adipogenic markers upon coculture with bone marrow adipocytes. Differentiation. 2010;80(1):40-45.
[24] Angers S, Moon RT. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 2009;10(7):468-477.
[25] Geng X, Xiao L, Lin GF, et al. Lef/Tcf-dependent Wnt/beta-catenin signaling during Xenopus axis specification. FEBS Lett. 2003;547(1-3):1-6.
[26] Lee PN, Pang K, Matus DQ, et al. A WNT of things to come: evolution of Wnt signaling and polarity in cnidarians. Semin Cell Dev Biol. 2006;17(2):157-167.
[27] Zhou H, Mak W, Zheng Y, et al. Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J Biol Chem. 2008;283(4):1936-1945.
[28] Liu B,Tang J,Li SY,et al.Involvement of the Wnt signaling pathway and cell apoptosis in the rat hippocampus following cerebral ischemia/reperfusion injury.Neural Regen Res. 2013; 8(1): 70-75.
[29] Jullien N, Maudinet A, Leloutre B, et al. Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells. J Cell Biochem. 2012; 113(6):2047-2056.
[30] Tokuda H, Adachi S, Matsushima-Nishiwaki R, et al. Enhancement of basic fibroblast growth factor-stimulated VEGF synthesis by Wnt3a in osteoblasts. Int J Mol Med. 2011;27(6):859-864.
[31] Li HX, Luo X, Liu RX, et al. Roles of Wnt/beta-catenin signaling in adipogenic differentiation potential of adipose-derived mesenchymal stem cells. Mol Cell Endocrinol. 2008;291(1-2):116-124.
[32] Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006;116(5):1202-1209.
[33] Holmen SL, Zylstra CR, Mukherjee A, et al. Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem. 2005; 280(22):21162-21168.
[34] Mbalaviele G, Sheikh S, Stains JP, et al. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J Cell Biochem. 2005;94(2):403-418.
[35] Deschaseaux F, Sensébé L, Heymann D. Mechanisms of bone repair and regeneration. Trends Mol Med. 2009;15(9): 417-429. |